Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Almirall Aesthetics Takeover

This article was originally published in Scrip

Executive Summary

Dermatology focused Almirall has announced that it will be exercising a call option to acquire 100% of aesthetics technology company ThermiGen LLC. Almirall plans to complete the acquisition by Jan. 31st 2016, with hopes to create a profile in the aesthetics market to strengthen its presence in derma.


Related Content

Sun Builds On Tildrakizumab Hopes With Almirall Pact


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts